Search Results - "Bellos, Frauke"
-
1
Flow cytometry in the diagnosis of myelodysplastic syndromes and the value of myeloid nuclear differentiation antigen
Published in Cytometry. Part B, Clinical cytometry (01-05-2017)“…Background Confirming diagnosis of myelodysplastic syndromes (MDS) is often challenging. Standard diagnostic methods are cytomorphology (CM) and cytogenetics…”
Get full text
Journal Article -
2
The molecular profile of adult T-cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL
Published in Genes chromosomes & cancer (01-04-2013)“…T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive and heterogeneous disease. The diagnosis is predominantly based on immunophenotyping. In addition…”
Get full text
Journal Article -
3
Automated Comprehensive Diagnostics of Hematologic Neoplasms By Artificial Intelligence Models Using Flow Cytometric Raw Matrix Data
Published in Blood (05-11-2021)“…Abstract Background: Artificial intelligence (AI) has steadily been entering the field supporting diagnostic workup of hematological neoplasms. Its application…”
Get full text
Journal Article -
4
Incidential Findings of Mutations in the PIGA Gene Are Highly Specific for the Presence of PNH Clones
Published in Blood (23-11-2021)“…Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a hemolytic anemia associated with severe thrombophilia and characterized by complement-mediated lysis…”
Get full text
Journal Article -
5
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93
Published in Genes chromosomes & cancer (01-06-2014)“…B lymphoblastic leukemia/lymphoma (ALL) are subdivided by the WHO classification into five subgroups defined by specific translocations and two further…”
Get full text
Journal Article -
6
Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients
Published in Onkologie (01-11-2008)“…Currently, no standard treatment is available for elderly patients with de novo/secondary acute myeloid leukemia (AML) who are not eligible for intensive…”
Get more information
Journal Article -
7
ELN IMDS Flow Working Group Validation of the Monocyte Assay for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry
Published in Blood (23-11-2021)“…▪ Introduction It was proposed that peripheral blood (PB) monocyte subset analysis evaluated by flow cytometry, hereafter referred to as “monocyte assay”,…”
Get full text
Journal Article -
8
Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes
Published in Blood (23-11-2021)“…Background: Myelodysplastic syndromes (MDS) are considered clonal diseases and are diagnosed according to WHO by cytomorphology and cytogenetics. The…”
Get full text
Journal Article -
9
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry
Published in Cytometry. Part B, Clinical cytometry (01-01-2023)“…Background: It was proposed that peripheral blood (PB) monocyte profiles evaluated by flow cytometry, called “monocyte assay,” could rapidly and efficiently…”
Get full text
Journal Article -
10
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q
Published in Blood (20-09-2012)“…The European LeukemiaNet classification combines a heterogeneous group of aberrations as adverse-risk abnormalities. Our goal was to investigate the outcomes…”
Get full text
Journal Article -
11
Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters
Published in Blood (03-12-2015)“…Background: Systemic mastocytosis (SM) is rarely diagnosed and presents with highly variable clinical manifestation from taking rather indolent to very…”
Get full text
Journal Article -
12
Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry
Published in Blood (03-12-2015)“…Background: Diagnostic workup for suspected myelodysplastic syndromes (MDS) is increasingly done with the aid of multiparamter flow cytometry (MFC) detecting…”
Get full text
Journal Article -
13
Flow cytometry in the diagnosis of myelodysplastic syndromes (MDS) and the value of myeloid nuclear differentiation antigen (MNDA)
Published in Cytometry. Part B, Clinical cytometry (25-09-2014)“…Background: Confirming diagnosis of myelodysplastic syndromes (MDS) is often challenging. Standard diagnostic methods are cytomorphology (CM) and cytogenetics…”
Get full text
Journal Article -
14
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet
Published in Cytometry. Part B, Clinical cytometry (01-01-2023)“…Background Flow cytometry (FCM) aids the diagnosis and prognostic stratification of patients with suspected or confirmed myelodysplastic syndrome (MDS). Over…”
Get full text
Journal Article -
15
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group
Published in Cytometry. Part B, Clinical cytometry (01-01-2023)“…This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and…”
Get full text
Journal Article -
16
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group
Published in Cytometry. Part B, Clinical cytometry (01-01-2023)“…Background Myelodysplastic syndromes (MDS) represent a diagnostic challenge. This prospective multicenter study was conducted to evaluate pre‐defined flow…”
Get full text
Journal Article -
17
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues
Published in Cytometry. Part B, Clinical cytometry (01-01-2023)“…Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) investigation of patients with cytopenia and suspected…”
Get full text
Journal Article -
18
Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance
Published in Experimental hematology (01-02-2012)“…Leukemia stem cell candidates (LSCC) can be enriched from patients with acute myeloid leukemia by high aldehyde dehydrogenase (ALDH) activity and CD34…”
Get full text
Journal Article -
19
Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
Published in European journal of haematology (01-02-2020)“…Introduction Targeting the cell cycle machinery represents a rational therapeutic approach in myelodysplastic syndromes (MDS) and secondary acute myeloid…”
Get full text
Journal Article -
20
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant
Published in Leukemia & lymphoma (01-12-2014)Get full text
Journal Article